Mattis Ranthe, MD, PhD
Mattis Ranthe, MD, PhD
Unknown affiliation
Verified email at ssi.dk
Title
Cited by
Cited by
Year
Familial aggregation of lone atrial fibrillation in young persons
N Øyen, MF Ranthe, L Carstensen, HA Boyd, MS Olesen, SP Olesen, ...
Journal of the American College of Cardiology 60 (10), 917-921, 2012
1012012
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
C Rungoe, S Basit, MF Ranthe, J Wohlfahrt, E Langholz, T Jess
Gut 62 (5), 689-694, 2013
952013
Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
Jama 315 (10), 1026-1033, 2016
752016
Risk of cardiovascular disease in family members of young sudden cardiac death victims
MF Ranthe, BG Winkel, EW Andersen, B Risgaard, J Wohlfahrt, ...
European heart journal 34 (7), 503-511, 2013
642013
Pregnancy loss and later risk of atherosclerotic disease
MF Ranthe, EAW Andersen, J Wohlfahrt, H Bundgaard, M Melbye, ...
Circulation 127 (17), 1775-1782, 2013
572013
Family history of premature death and risk of early onset cardiovascular disease
MF Ranthe, L Carstensen, N Øyen, J Tfelt-Hansen, M Christiansen, ...
Journal of the American College of Cardiology 60 (9), 814-821, 2012
482012
Cardiac involvement in myotonic dystrophy: a nationwide cohort study
M Lund, LJ Diaz, MF Ranthe, H Petri, M Duno, I Juncker, H Eiberg, ...
European heart journal 35 (32), 2158-2164, 2014
452014
A detailed family history of myocardial infarction and risk of myocardial infarction–a nationwide cohort study
MF Ranthe, JA Petersen, H Bundgaard, J Wohlfahrt, M Melbye, HA Boyd
PloS one 10 (5), 2015
192015
Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based …
B Pasternak, H Svanström, MF Ranthe, M Melbye, A Hviid
CNS drugs 28 (10), 963-973, 2014
192014
Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation
G Ahlberg, L Refsgaard, PR Lundegaard, L Andreasen, MF Ranthe, ...
Nature communications 9 (1), 1-11, 2018
172018
Heart Disease and Stroke Statistics—2014 Update: A Report from the American Heart Association. 2014
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Epub ahead of print, 2014
122014
Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
PloS one 14 (2), 2019
82019
Risk of cardiomyopathy in younger persons with a family history of death from cardiomyopathy: a nationwide family study in a cohort of 3.9 million persons
MF Ranthe, L Carstensen, N Øyen, MK Jensen, A Axelsson, J Wohlfahrt, ...
Circulation 132 (11), 1013-1019, 2015
82015
Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study
MF Ranthe, LJ Diaz, I Behrens, H Bundgaard, J Simonsen, M Melbye, ...
European heart journal 37 (11), 900-907, 2016
72016
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: a DEVOTE subanalysis (DEVOTE 10)
K Brown‐Frandsen, SS Emerson, DK McGuire, TR Pieber, NR Poulter, ...
Diabetes, Obesity and Metabolism 21 (6), 1437-1444, 2019
62019
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
I Lingvay, S Harris, E Jaeckel, K Chandarana, MF Ranthe, E Jódar
Diabetes, Obesity and Metabolism 20 (1), 200-205, 2018
52018
Miscarriage and cardiovascular disease
MF Ranthe, HA Boyd
Heart 101 (24), 1933-1934, 2015
42015
Insulin degludec/liraglutide (ID egLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that …
L Meneghini, A Doshi, D Gouet, T Vilsbøll, K Begtrup, P Őrsy, MF Ranthe, ...
Diabetic Medicine, 2019
22019
Co-occurrence of infantile hypertrophic pyloric stenosis and congenital heart defects: a nationwide cohort study
B Feenstra, S Gørtz, M Lund, MF Ranthe, F Geller, M Melbye
Pediatric research 85 (7), 955-960, 2019
22019
The clinical benefits of IDegLira in DUAL VII were achieved while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy
EM Miller, E Jodar, K Khunti, D Sugimoto, P Orsy, MF Ranthe, A Viljoen
Diabetologia 61, S43-S44, 2018
22018
The system can't perform the operation now. Try again later.
Articles 1–20